The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma

Overview of attention for article published in OncoTargets and therapy, January 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Development a novel drug delivery formulation targeting to esophageal squamous cell carcinoma

Article in Materials Today Advances (August 2023)

Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer

Article in International Journal of Molecular Sciences (July 2023)

Repositioning study of flubendazole for treating lung cancer and meningoencephalitis using an oral lipid nanosystem

Article (May 2023)